Uplisting Could Reprice U.S. Cannabis Stocks
Jason Spatafora
Thu, Mar 19
U.S. cannabis stocks could see a multi-billion dollar rerating if uplistings to major exchanges unlock institutional liquidity and wider investor access.
Share your feedback with us
If you're passionate about plant medicine and excited by our mission, we'd love to hear your perspective on how we can best meet your needs.
Share Feedback Join our waitlist
Join our waitlist today to get ahead of the curve and become a part of this trailblazing community.
Join Today Share with friends
Invite your friends to be part of this trailblazing community revolutionizing mental health, physical wellbeing, and human consciousness.